Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

BLRX

BLRX News

Newswire

14:34

BioLineRx shares surge 10.4% intraday after key US patent approval for cancer drug GLIX1.

07:05

BioLineRx Establishes Joint Venture for Glioblastoma Treatment

16:05

Earnings Preview: CAAP, BLRX Set to Report on Nov 24, 2025

09:34

BioLineRx Q3 2025 Earnings Preview: EPS Estimate at -$0.54, Revenue Estimate at $0.67M

20:28

Healthcare Stocks in Focus: 12 Stocks Moving in Wednesday's After-Market Session

View More

About BLRX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More